companydata.dkcompanydata.dk

BACH BOLIGCENTER ApS: Financial statements 2026

CVR: 12024584

Source: annual report 2026, Danish Business Authority

01/04/2025 – 31/03/2026

BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122. The solvency ratio was 93.2%. The company had 1 employee in the financial year.

Gross Profit
DKK -12,635
Profit/Loss
DKK 3,958
Equity
DKK 243,122
Total Assets
DKK 260,950
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2026--13K4K243K1
2025--20K-36K307K1
2024--20K38K404K1
2023--15K-201K424K1
2022--14K-153K682K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like BACH BOLIGCENTER ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

About BACH BOLIGCENTER ApS

BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.

Source: annual report 2026, Danish Business Authority